These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
595 related items for PubMed ID: 7664682
21. Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labor in the human myometrium. Stevens MY, Challis JR, Lye SJ. J Clin Endocrinol Metab; 1998 Nov; 83(11):4107-15. PubMed ID: 9814500 [Abstract] [Full Text] [Related]
22. Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. Sangha RK, Walton JC, Ensor CM, Tai HH, Challis JR. J Clin Endocrinol Metab; 1994 Apr; 78(4):982-9. PubMed ID: 8157731 [Abstract] [Full Text] [Related]
24. Cellular localization of corticotrophin releasing hormone in the human placenta, fetal membranes and decidua. Warren WB, Silverman AJ. Placenta; 1995 Mar; 16(2):147-56. PubMed ID: 7792278 [Abstract] [Full Text] [Related]
27. Corticotropin-releasing hormone and cortisol in cord plasma in relation to gestational age, labor, and fetal distress. Ruth V, Hallman M, Laatikainen T. Am J Perinatol; 1993 Mar; 10(2):115-8. PubMed ID: 8476473 [Abstract] [Full Text] [Related]
28. [Expression of corticotropin-releasing hormone and its receptor type-1 in the placental cotyledon vessels]. Wang XD, Yu HY, Yao Q, Liu SY. Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):634-6. PubMed ID: 16235524 [Abstract] [Full Text] [Related]
30. Localization and characterization of urocortin during human pregnancy. Clifton VL, Gu Q, Murphy VE, Schwartz J, Madsen G, Smith R. Placenta; 2000 Nov; 21(8):782-8. PubMed ID: 11095927 [Abstract] [Full Text] [Related]
31. The human prolactin receptor in the fetal membranes, decidua, and placenta. Maaskant RA, Bogic LV, Gilger S, Kelly PA, Bryant-Greenwood GD. J Clin Endocrinol Metab; 1996 Jan; 81(1):396-405. PubMed ID: 8550784 [Abstract] [Full Text] [Related]
32. Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition. Voltolini C, Battersby S, Novembri R, Torricelli M, Severi FM, Petraglia F, Norman JE. Endocrinology; 2015 Feb; 156(2):670-9. PubMed ID: 25426872 [Abstract] [Full Text] [Related]
33. Corticotropin-releasing hormone-binding protein in primates. Bowman ME, Lopata A, Jaffe RB, Golos TG, Wickings J, Smith R. Am J Primatol; 2001 Mar; 53(3):123-30. PubMed ID: 11253847 [Abstract] [Full Text] [Related]
35. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Han VK, Bassett N, Walton J, Challis JR. J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597 [Abstract] [Full Text] [Related]
36. Levels of corticotropin-releasing hormone messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus and proopiomelanocortin mRNA in the anterior pituitary during late gestation in fetal sheep. Myers DA, Myers TR, Grober MS, Nathanielsz PW. Endocrinology; 1993 May; 132(5):2109-16. PubMed ID: 8386607 [Abstract] [Full Text] [Related]
38. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. Sun K, Yang K, Challis JR. J Clin Endocrinol Metab; 1997 Jan; 82(1):300-5. PubMed ID: 8989277 [Abstract] [Full Text] [Related]